购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

Celecoxib

Rating icon 很棒
产品编号 T0466Cas号 169590-42-5
别名 塞来昔布, 塞来西布, SC 58635

Celecoxib (SC 58635) 是一种非甾体抗炎剂,是 一种 COX-2 抑制剂 (IC50=40 nM),具有选择性。Celecoxib 具有抗炎和止痛活性,可以用于治疗骨关节炎、类风湿性关节炎、急性疼痛等。

Celecoxib
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

Celecoxib

Rating icon 很棒
纯度: 100%
产品编号 T0466 别名 塞来昔布, 塞来西布, SC 58635Cas号 169590-42-5

Celecoxib (SC 58635) 是一种非甾体抗炎剂,是 一种 COX-2 抑制剂 (IC50=40 nM),具有选择性。Celecoxib 具有抗炎和止痛活性,可以用于治疗骨关节炎、类风湿性关节炎、急性疼痛等。

规格价格库存数量
25 mg¥ 228现货
50 mg¥ 345现货
100 mg¥ 541现货
200 mg¥ 746现货
1 g¥ 1,869现货
1 mL x 10 mM (in DMSO)¥ 228现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"Celecoxib"的相关化合物库

选择批次:
纯度:99.98%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
Celecoxib (SC 58635) is a non-steroidal anti-inflammatory agent, a COX-2 inhibitor (IC50=40 nM), with selectivity. Celecoxib has anti-inflammatory and analgesic activity and can be used for the treatment of osteoarthritis, rheumatoid arthritis, and acute pain.
靶点活性
COX-2:40 nM
体外活性
方法:鼻咽癌 (NPC) 细胞系 HNE1 和 CNE1-LMP1 用 Celecoxib (5-75 µM) 处理 48 h,使用 MTT assay 检测细胞活力。
结果:Celecoxib 的抑制作用以剂量依赖的方式发生。Celecoxib 在 HNE1 和 CNE1-LMP1 中的平均 IC50 值分别为 32.86±1.13 µmol/L 和 61.31±4.30 µmol/L。[1]
方法:人正常肝细胞 L02 用 PA (200 µM) 和 Celecoxib (5-40 µM) 处理 24 h,使用 Western Blot 检测靶点蛋白表达水平。
结果:PA 诱导 COX-2 上调,LC3 II/I 和 p62 的蛋白质表达增加。PA和 Celecoxib 联用,COX-2 和 p62 的蛋白水平显著降低,LC3 II/I 增加。[2]
体内活性
方法:为测试是否能降低放射性肺炎的死亡率,将 Celecoxib (25  mg/kg in 0.5% methyl cellulose and 0.025% Tween 20 in sterile water) 灌胃给药给局部胸部照射 (LTI) 的 C3Hf/KamLaw 小鼠。从 LTI 当天或 40 或 80 天后开始给药,每天两次,持续四十天。
结果:Celecoxib 相对于 LTI 的时间决定了疗效。只有当 Celecoxib 在 LTI 后 80 天开始使用时,死亡时间才能显著缩短,这与肺炎的表达时间相对应。对于这些小鼠,死亡率的降低被量化为治疗组与未治疗组的死亡率的风险比为 0.36。[3]
激酶实验
COX enzyme assay in vitro: Expression of COX protein in insect cells is determined by assessing PG-synthetic capability in homogenates from cells incubated for 3 days with COX-1 or COX-2 baculovirus. Cells expressing COX-1 or COX-2 are homogenized and incubated with arachidonic acid (10 μM). COX activity is determined by monitoring PG production. No COX activity is detected in mock-infected Sf9 cells. Celecoxib are preincubated with crude 1% CHAPS homogenates (2-10 μg of protein) for 10 minutes before addition of arachidonic acid. PGE2 formed is detected by ELISA after 10 minute incubation.
细胞实验
The antiproliferative effect of Celecoxib on NPC cells is assessed using an MTT assay. Cells are seeded into 96-well plates and allowed to attach for 24 hours. The cells are then treated with increasing concentrations of Celecoxib (0 to 75 μM) dissolved in DMSO (final concentration ≤0.1%) and incubated for up to 48 hours. After the incubation, 20 μL of MTT dye (5 mg/mL) are added to each well and cells are incubated at 37 °C for 4 hours. After removing the supernatants, the crystals are dissolved in DMSO and the absorbance is measured at 490 nm. The half-maximal inhibitory concentration (IC50) values and the 95% confidence intervals are calculated using probit regression using SPSS 15.0 software. The experiment is performed in triplicate and repeated at least three times.(Only for Reference)
别名塞来昔布, 塞来西布, SC 58635
化学信息
分子量381.37
分子式C17H14F3N3O2S
CAS No.169590-42-5
SmilesC(F)(F)(F)C1=NN(C(=C1)C2=CC=C(C)C=C2)C3=CC=C(S(N)(=O)=O)C=C3
密度1.43 g/cm3 (Predicted)
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 7.1 mg/mL (18.62 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
Ethanol: 31 mg/mL (81.3 mM)
2% DMSO+40% PEG300+5% Tween 80+53% H2O: 3 mg/mL (7.87 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
DMSO: 60 mg/mL (157.33 mM)
溶液配制表
1mg5mg10mg50mg
1 mM2.6221 mL13.1106 mL26.2213 mL131.1063 mL
5 mM0.5244 mL2.6221 mL5.2443 mL26.2213 mL
1mg5mg10mg50mg
10 mM0.2622 mL1.3111 mL2.6221 mL13.1106 mL
1mg5mg10mg50mg
20 mM0.1311 mL0.6555 mL1.3111 mL6.5553 mL
50 mM0.0524 mL0.2622 mL0.5244 mL2.6221 mL
1mg5mg10mg50mg
100 mM0.0262 mL0.1311 mL0.2622 mL1.3111 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy Celecoxib | purchase Celecoxib | Celecoxib cost | order Celecoxib | Celecoxib chemical structure | Celecoxib in vivo | Celecoxib in vitro | Celecoxib formula | Celecoxib molecular weight